Hey Pledge - the product did change- Prochymal was inferior to Ryoncil. Which is why ,imo, the ODAC vote was overturned.
Different management too - particularly Dr Eric Rose and Dr Philip Krause.
If the potency assay gets knocked back then the CEO and most of the board need to go. Nippy also gets to buy at 0.02c.
I get the feeling they have given the FDA ( new leadership) what they need- or they would not have submitted- given that PK has stated the prior submission answered most of the requirements of the last CRL leaving potency data as the outstanding issue. Does not mean we get approved but will definitely put a floor under the price.
You are waiting for under 30c, I'm waiting for 31c.
Big week one way or the other to finish off March.
We missed the Ides of March - perhaps celebrating a crucifixion in April would be more to your liking
Reg
Partnership deals......, page-69
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
0.010(1.02%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 98.5¢ | $5.507M | 5.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9996 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 18069 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |